×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PVCT – provectus biopharms (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PVCT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/9
08:12 pm
pvct
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy [Yahoo! Finance]
Medium
Report
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy [Yahoo! Finance]
10/9
08:00 am
pvct
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
Low
Report
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
9/29
08:00 am
pvct
Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer
Low
Report
Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/1
09:52 pm
pvct
Form SCHEDULE 13D/A PROVECTUS BIOPHARMACEUTI Filed by: Pershing Edward
Medium
Report
Form SCHEDULE 13D/A PROVECTUS BIOPHARMACEUTI Filed by: Pershing Edward
11/28
12:40 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 26 Filed by: Pershing Edward
Neutral
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 26 Filed by: Pershing Edward
11/21
01:48 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 20 Filed by: Pershing Edward
Low
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 20 Filed by: Pershing Edward
11/14
12:55 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 13 Filed by: Pershing Edward
Medium
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 13 Filed by: Pershing Edward
11/13
02:37 pm
pvct
Form 10-Q PROVECTUS BIOPHARMACEUTI For: Sep 30
Neutral
Report
Form 10-Q PROVECTUS BIOPHARMACEUTI For: Sep 30
11/7
10:39 am
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 06 Filed by: Pershing Edward
Low
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 06 Filed by: Pershing Edward
10/31
04:10 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Oct 30 Filed by: Pershing Edward
Neutral
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Oct 30 Filed by: Pershing Edward
10/24
04:49 pm
pvct
Form 4 PROVECTUS BIOPHARMACEUTI For: Oct 23 Filed by: Pershing Edward
Medium
Report
Form 4 PROVECTUS BIOPHARMACEUTI For: Oct 23 Filed by: Pershing Edward
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: